These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
248 related articles for article (PubMed ID: 33320969)
1. Polymeric nanoencapsulation of zaleplon into PLGA nanoparticles for enhanced pharmacokinetics and pharmacological activity. Haggag YA; Abosalha AK; Tambuwala MM; Osman EY; El-Gizawy SA; Essa EA; Donia AA Biopharm Drug Dispos; 2021 Jan; 42(1):12-23. PubMed ID: 33320969 [TBL] [Abstract][Full Text] [Related]
2. Brain Targeted Intranasal Zaleplon Nano-emulsion: In-Vitro Characterization and Assessment of Gamma Aminobutyric Acid Levels in Rabbits' Brain and Plasma at Low and High Doses. Abd-Elrasheed E; El-Helaly SN; El-Ashmoony MM; Salah S Curr Drug Deliv; 2018; 15(6):898-906. PubMed ID: 29189154 [TBL] [Abstract][Full Text] [Related]
3. Sustained release and enhanced oral bioavailability of rivaroxaban by PLGA nanoparticles with no food effect. Anwer MK; Mohammad M; Iqbal M; Ansari MN; Ezzeldin E; Fatima F; Alshahrani SM; Aldawsari MF; Alalaiwe A; Alzahrani AA; Aldayel AM J Thromb Thrombolysis; 2020 Apr; 49(3):404-412. PubMed ID: 31898270 [TBL] [Abstract][Full Text] [Related]
4. Daunorubicin oral bioavailability enhancement by surface coated natural biodegradable macromolecule chitosan based polymeric nanoparticles. Ahmad N; Ahmad R; Alam MA; Ahmad FJ; Amir M; Pottoo FH; Sarafroz M; Jafar M; Umar K Int J Biol Macromol; 2019 May; 128():825-838. PubMed ID: 30690115 [TBL] [Abstract][Full Text] [Related]
5. Improvement of oral efficacy of Irinotecan through biodegradable polymeric nanoparticles through in vitro and in vivo investigations. Ahmad N; Alam MA; Ahmad R; Umar S; Jalees Ahmad F J Microencapsul; 2018 Jun; 35(4):327-343. PubMed ID: 29873288 [TBL] [Abstract][Full Text] [Related]
6. Rapid oral transmucosal delivery of zaleplon-lavender oil utilizing self-nanoemulsifying lyophilized tablets technology: development, optimization and pharmacokinetic evaluation. Ali SA; Alhakamy NA; Hosny KM; Alfayez E; Bukhary DM; Safhi AY; Badr MY; Mushtaq RY; Alharbi M; Huwaimel B; Alissa M; Alshehri S; Alamri AH; Alqahtani T Drug Deliv; 2022 Dec; 29(1):2773-2783. PubMed ID: 36036168 [TBL] [Abstract][Full Text] [Related]
7. Lipid nanoparticles of zaleplon for improved oral delivery by Box-Behnken design: optimization, in vitro and in vivo evaluation. Dudhipala N; Janga KY Drug Dev Ind Pharm; 2017 Jul; 43(7):1205-1214. PubMed ID: 28274147 [TBL] [Abstract][Full Text] [Related]
8. Brain-targeted intranasal zaleplon solid dispersion in hydrophilic carrier system; 2 Abd-Elrasheed E; Nageeb El-Helaly S; El-Ashmoony MM; Salah S Drug Dev Ind Pharm; 2018 May; 44(5):741-749. PubMed ID: 29235903 [TBL] [Abstract][Full Text] [Related]
9. Uniform carboxymethyl chitosan-enveloped Pluronic F68/poly(lactic-co-glycolic acid) nano-vehicles for facilitated oral delivery of gefitinib, a poorly soluble antitumor compound. Wang J; Wang F; Li X; Zhou Y; Wang H; Zhang Y Colloids Surf B Biointerfaces; 2019 May; 177():425-432. PubMed ID: 30798063 [TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic profile of chitosan modified poly lactic co-glycolic acid biodegradable nanoparticles following oral delivery of gentamicin in rabbits. Akhtar B; Muhammad F; Aslam B; Saleemi MK; Sharif A Int J Biol Macromol; 2020 Dec; 164():1493-1500. PubMed ID: 32735923 [TBL] [Abstract][Full Text] [Related]
11. PLGA nanoparticles for the oral delivery of nuciferine: preparation, physicochemical characterization and in vitro/in vivo studies. Liu Y; Wu X; Mi Y; Zhang B; Gu S; Liu G; Li X Drug Deliv; 2017 Nov; 24(1):443-451. PubMed ID: 28165858 [TBL] [Abstract][Full Text] [Related]
12. HPMA-PLGA Based Nanoparticles for Effective In Vitro Delivery of Rifampicin. Rani S; Gothwal A; Pandey PK; Chauhan DS; Pachouri PK; Gupta UD; Gupta U Pharm Res; 2018 Dec; 36(1):19. PubMed ID: 30511238 [TBL] [Abstract][Full Text] [Related]
13. Docetaxel-loaded PLGA and PLGA-PEG nanoparticles for intravenous application: pharmacokinetics and biodistribution profile. Rafiei P; Haddadi A Int J Nanomedicine; 2017; 12():935-947. PubMed ID: 28184163 [TBL] [Abstract][Full Text] [Related]
14. PLGA Nanoparticle Platform for Trans-Ocular Barrier to Enhance Drug Delivery: A Comparative Study Based on the Application of Oligosaccharides in the Outer Membrane of Carriers. Jiang G; Jia H; Qiu J; Mo Z; Wen Y; Zhang Y; Wen Y; Xie Q; Ban J; Lu Z; Chen Y; Wu H; Ni Q; Chen F; Lu J; Wang Z; Li H; Chen J Int J Nanomedicine; 2020; 15():9373-9387. PubMed ID: 33262593 [TBL] [Abstract][Full Text] [Related]
15. Oral pentamidine-loaded poly(d,l-lactic-co-glycolic) acid nanoparticles: an alternative approach for leishmaniasis treatment. Valle IV; Machado ME; Araújo CDCB; da Cunha-Junior EF; da Silva Pacheco J; Torres-Santos EC; da Silva LCRP; Cabral LM; do Carmo FA; Sathler PC Nanotechnology; 2019 Nov; 30(45):455102. PubMed ID: 31365912 [TBL] [Abstract][Full Text] [Related]
16. Biodegradable polymeric nanoparticles for oral delivery of epirubicin: In vitro, ex vivo, and in vivo investigations. Tariq M; Alam MA; Singh AT; Iqbal Z; Panda AK; Talegaonkar S Colloids Surf B Biointerfaces; 2015 Apr; 128():448-456. PubMed ID: 25769281 [TBL] [Abstract][Full Text] [Related]
17. Preparation and Evaluation of Irinotecan Poly(Lactic-co-Glycolic Acid) Nanoparticles for Enhanced Anti-tumor Therapy. Yang X; Yang Y; Jia Q; Hao Y; Liu J; Huang G AAPS PharmSciTech; 2019 Feb; 20(3):133. PubMed ID: 30820689 [TBL] [Abstract][Full Text] [Related]
18. Preparation and characterization of surface-modified PLGA-polymeric nanoparticles used to target treatment of intestinal cancer. Ahmad N; Alam MA; Ahmad R; Naqvi AA; Ahmad FJ Artif Cells Nanomed Biotechnol; 2018 Mar; 46(2):432-446. PubMed ID: 28503995 [TBL] [Abstract][Full Text] [Related]
19. Chitosan Oleate Coated Poly Lactic-Glycolic Acid (PLGA) Nanoparticles versus Chitosan Oleate Self-Assembled Polymeric Micelles, Loaded with Resveratrol. Miele D; Catenacci L; Sorrenti M; Rossi S; Sandri G; Malavasi L; Dacarro G; Ferrari F; Bonferoni MC Mar Drugs; 2019 Sep; 17(9):. PubMed ID: 31480614 [TBL] [Abstract][Full Text] [Related]
20. Effect of different molecular weight PLGA on flurbiprofen nanoparticles: formulation, characterization, cytotoxicity, and Öztürk AA; Yenilmez E; Şenel B; Kıyan HT; Güven UM Drug Dev Ind Pharm; 2020 Apr; 46(4):682-695. PubMed ID: 32281428 [No Abstract] [Full Text] [Related] [Next] [New Search]